Compare Aether Industri. with Similar Stocks
Dashboard
Company has a low Debt to Equity ratio (avg) at 0.02 times
Healthy long term growth as Net Sales has grown by an annual rate of 21.16% and Operating profit at 26.18%
With a growth in Net Profit of 19.5%, the company declared Outstanding results in Dec 25
Majority shareholders : Promoters
Market Beating Performance
Stock DNA
Specialty Chemicals
INR 14,544 Cr (Small Cap)
70.00
36
0.00%
0.07
8.71%
6.21
Total Returns (Price + Dividend) 
Aether Industri. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Broad-Based Technical Strength Lifts Aether Industries Ltd to 52-Week High of Rs 1243.7
With a decisive surge to Rs 1243.7 on 24 Mar 2026, Aether Industries Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This rally is underscored by a confluence of bullish technical indicators and sustained volume support, setting the stage for a compelling momentum narrative in the specialty chemicals sector.
Read full news article
Aether Industries Ltd Hits All-Time High of Rs 1,189.45 as Momentum Builds Across Timeframes
Extending its remarkable rally, Aether Industries Ltd surged 11.82% on 24 Mar 2026 to touch a fresh all-time high of Rs 1,189.45, significantly outpacing the Sensex gain of 1.88% and the Chemicals sector's 2.57% advance. This milestone caps a strong performance trajectory that has seen the stock outperform the broader market by a wide margin over multiple timeframes.
Read full news article
Aether Industries Ltd Surges 7.38% to Day's High of Rs 1163 — Outperforms Sector by 4.78 Percentage Points
The Sensex advanced 2.1% on 24 Mar 2026, yet Aether Industries Ltd outpaced the broader market with a 7.38% gain, reaching an intraday high of Rs 1163. This 4.78-percentage-point outperformance over the Specialty Chemicals sector’s 2.6% rise highlights a distinctly stock-specific rally on a day of broad market strength.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
20-Mar-2026 | Source : BSEFurther with reference to the intimation dated March 10 2026 submitted vide Ref. No. AIL/SE/71/2025-26 in accordance with Regulation 30 and all other applicable provisions of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended we herewith inform that Company Officials had in person Meeting (including site visit) with an Investor today at Company premises as annexed.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
14-Mar-2026 | Source : BSEIn accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended from time to time and further to our correspondence having Ref. No.: AIL/SE/71/2025-26 dated March 10 2026 we hereby make a correction in name of the Investor as annexed.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
13-Mar-2026 | Source : BSEFurther with reference to the intimation dated March 4 2026 submitted vide Ref. No. AIL/SE/70/2025-26 in accordance with Regulation 30 and all other applicable provisions of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended we herewith inform that Company Officials had in person Meeting (including site visit) with an Investor today at Company premises as annexed.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 12 Schemes (11.07%)
Held by 81 FIIs (5.81%)
Purnima Ashwin Desai (17.4%)
Sbi Multicap Fund (8.63%)
5.43%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 13.22% vs 9.35% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is 19.50% vs 14.76% in Sep 2025






